Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma
Austin J. Sim(Moffitt Cancer Center), Michael D. Jain(Moffitt Cancer Center), Nicholas Figura(Moffitt Cancer Center), Julio C. Chávez(University of South Florida), Bijal Shah(Moffitt Cancer Center), Farhad Khimani(Moffitt Cancer Center), Aleksandr Lazaryan(Moffitt Cancer Center), Gabriel Krivenko(Moffitt Cancer Center), Marco L. Davila(Moffitt Cancer Center), Hien Liu(Moffitt Cancer Center), Aaron D. Falchook(Memorial Hospital), Saurabh Dahiya(University of Maryland, Baltimore), Aaron P. Rapoport(University of Maryland, Baltimore), Sungjune Kim(Moffitt Cancer Center), Frederick L. Locke(Moffitt Cancer Center), Timothy J. Robinson(Moffitt Cancer Center)
Cited by 162
Abstract
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett et al.|New England Journal of Medicine|2017|5.9k
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson, Richard I. Fisher, Sally F. Barrington et al.|Journal of Clinical Oncology|2014|5.5k
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
Sattva S. Neelapu, Sudhakar Tummala, Partow Kebriaei et al.|Nature Reviews Clinical Oncology|2017|2.4k